Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells

Overexpression of human epidermal growth factor receptor (EGFR) has been detected in gastric cancer (GC) and is associated with poor outcomes. Combination treatment regimens with EGFR-targeting agents and cytotoxic agents are considered to be a potential therapeutic option for EGFR-overexpressing GC...

Descripción completa

Detalles Bibliográficos
Autores principales: FUKUDA, KAZUMASA, SAIKAWA, YOSHIRO, TAKAHASHI, MASASHI, TAKAHASHI, TSUNEHIRO, WADA, NORIHITO, KAWAKUBO, HIROHUMI, TAKEUCHI, HIROYA, KITAGAWA, YUKO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584625/
https://www.ncbi.nlm.nih.gov/pubmed/22139134
http://dx.doi.org/10.3892/ijo.2011.1279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584625/
https://www.ncbi.nlm.nih.gov/pubmed/22139134
http://dx.doi.org/10.3892/ijo.2011.1279

Ejemplares similares